Brazilian education holding company Anima Holding SA has reached an agreement to sell 25% of its medical education subsidiary Inspirali to health-focused investment fund DNA Capital for 1 billion reais ($179 million), it said in a Monday securities filing.
Inspirali, according to Anima, is the second-largest medical education company in Brazil, with close to 10,000 students spread across the country. The unit reported net revenue of 436.6 million reais in the first nine months of 2021, Anima said.
DNA Capital has investments in more than 20 firms, including DASA, a major medical diagnostics company in Brazil.
The deal will need approval from Brazil’s competition watchdog, Cade, Anima said.
Source: Reuters.com